| Rank | Ticker | Country | Price | Revenue | Analyst Rating | Analysts | IPO Year |
|---|---|---|---|---|---|---|---|
#1 | SGHC | Guernsey | $10.48 | $2,342,912,011.00 | Strong Buy | 8 | N/A |
#2 | GLW | United States | $85.37 | $14,915,000,000.00 | Strong Buy | 12 | N/A |
#3 | ASIC | United States | $18.68 | $405,657,000.00 | Strong Buy | 4 | 2025 |
#4 | EQT | United States | $51.02 | $7,708,868,000.00 | Buy | 21 | N/A |
#5 | FVRR | Israel | $18.16 | $427,401,000.00 | Strong Buy | 10 | 2019 |
#6 | CWEN | United States | $32.03 | $1,375,000,000.00 | Strong Buy | 8 | 2013 |
#7 | AMX | Mexico | $20.32 | $51,012,503,011.00 | Buy | 6 | 2001 |
#8 | CALM | United States | $73.46 | $4,213,443,000.00 | Buy | 4 | 1996 |
#9 | DGII | United States | $40.71 | $430,221,000.00 | Strong Buy | 5 | N/A |
#10 | SRAD | Switzerland | $20.89 | $1,440,977,356.00 | Strong Buy | 18 | 2021 |
#11 | IMAX | Canada | $34.13 | $377,677,000.00 | Strong Buy | 9 | 1994 |
#12 | HMN | United States | $44.44 | $1,675,600,000.00 | Buy | 5 | 1991 |
#13 | BOW | United States | $25.01 | $519,241,000.00 | Buy | 6 | 2024 |
#14 | ZWS | United States | $46.08 | $1,659,400,000.00 | Buy | 6 | 2012 |
#15 | NFLX | United States | $89.38 | $43,378,787,000.00 | Buy | 36 | 2002 |
#16 | CTRA | United States | $24.84 | $6,666,000,000.00 | Buy | 16 | 1990 |
#17 | CART | United States | $41.15 | $3,633,000,000.00 | Buy | 24 | 2023 |
#18 | CSCO | United States | $73.85 | $57,696,000,000.00 | Buy | 17 | 1990 |
#19 | LVS | United States | $58.96 | $12,264,000,000.00 | Buy | 13 | 2004 |
#20 | LW | United States | $41.34 | $6,473,600,000.00 | Buy | 7 | N/A |
#21 | ODD | Israel | $35.39 | $780,758,000.00 | Buy | 11 | 2023 |
#22 | EPRT | United States | $29.50 | $531,061,000.00 | Buy | 11 | 2018 |
#23 | SR | United States | $82.04 | $2,476,400,000.00 | Buy | 10 | N/A |
#24 | FLEX | United States | $61.46 | $26,333,000,000.00 | Strong Buy | 8 | 1994 |
#25 | DEC | United States | $13.32 | $1,148,432,000.00 | Strong Buy | 6 | N/A |
#26 | ASMB | United States | $31.88 | $37,191,000.00 | Strong Buy | 6 | 2010 |
#27 | ARQT | United States | $28.21 | $317,929,000.00 | Strong Buy | 7 | 2020 |
#28 | RARE | United States | $22.56 | $630,598,000.00 | Strong Buy | 20 | 2014 |
#29 | URGN | United States | $21.29 | $96,516,000.00 | Strong Buy | 8 | 2017 |
#30 | TERN | United States | $35.50 | $0.00 | Strong Buy | 10 | 2021 |
#31 | TRVI | United States | $11.20 | $0.00 | Strong Buy | 12 | 2019 |
#32 | LGN | United States | $44.55 | $2,361,064,000.00 | Strong Buy | 15 | 2025 |
#33 | TAC | Canada | $12.37 | $1,783,342,546.00 | Strong Buy | 4 | N/A |
#34 | EYE | United States | $26.41 | $1,921,355,000.00 | Strong Buy | 9 | 2017 |
#35 | TGTX | United States | $28.42 | $531,898,000.00 | Strong Buy | 4 | 1995 |
#36 | PVLA | United States | $92.36 | $0.00 | Strong Buy | 17 | N/A |
#37 | TARS | United States | $76.88 | $366,100,000.00 | Strong Buy | 9 | 2020 |
#38 | VTR | United States | $74.86 | $5,544,046,000.00 | Buy | 14 | 1998 |
#39 | MAX | United States | $11.61 | $1,123,093,000.00 | Buy | 6 | 2020 |
#40 | JANX | United States | $14.18 | $10,000,000.00 | Strong Buy | 12 | 2021 |
#41 | OCUL | United States | $11.27 | $55,783,000.00 | Strong Buy | 10 | 2014 |
#42 | CNTA | United Kingdom | $22.36 | $15,000,000.00 | Strong Buy | 10 | 2021 |
#43 | HPE | United States | $22.18 | $34,296,000,000.00 | Buy | 18 | N/A |
#44 | WLTH | United States | $12.85 | $338,626,000.00 | Buy | 5 | 2025 |
#45 | RUN | United States | $18.11 | $2,316,656,000.00 | Buy | 17 | 2015 |
#46 | IMCR | United Kingdom | $32.95 | $379,590,000.00 | Buy | 11 | 2021 |
#47 | AR | United States | $31.46 | $5,007,754,000.00 | Buy | 18 | 2013 |
#48 | BBNX | United States | $20.31 | $88,570,000.00 | Strong Buy | 12 | 2025 |
#49 | RCUS | United States | $21.06 | $240,000,000.00 | Buy | 8 | 2018 |
#50 | EXTR | United States | $15.61 | $1,181,108,000.00 | Strong Buy | 5 | 1999 |
The FinQuota filters have identified what they believe to be the "Best Stocks Under $100 to Buy (January 12, 2026) | FinQuota" to buy now. However, please note that this information should not be considered as financial advice, as investing involves risks. We strongly recommend consulting with a qualified financial advisor before making any decisions regarding buying or selling stocks.